Literature DB >> 16104896

Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.

John S Lam1, John T Leppert, Arie S Belldegrun, Robert A Figlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104896     DOI: 10.1111/j.1464-410X.2005.05670.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  6 in total

1.  New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer.

Authors:  Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

2.  Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.

Authors:  Sarah M Cheal; Blesida Punzalan; Michael G Doran; Michael J Evans; Joseph R Osborne; Jason S Lewis; Pat Zanzonico; Steven M Larson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-07       Impact factor: 9.236

Review 3.  Adjuvant and neoadjuvant therapy in renal cell carcinoma.

Authors:  Michel Choueiri; Nizar Tannir; Eric Jonasch
Journal:  Curr Clin Pharmacol       Date:  2011-08

Review 4.  Adjuvant therapy for high-risk renal cell carcinoma patients.

Authors:  David A Kunkle; Naomi B Haas; Robert G Uzzo
Journal:  Curr Urol Rep       Date:  2007-01       Impact factor: 3.092

Review 5.  Adjuvant therapy for renal cell carcinoma.

Authors:  Naomi B Haas; Robert Uzzo
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

Review 6.  Systemic adjuvant therapies in renal cell carcinoma.

Authors:  Sebastiano Buti; Melissa Bersanelli; Maddalena Donini; Andrea Ardizzoni
Journal:  Oncol Rev       Date:  2012-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.